3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
Mirati Therapeutics Inc. (MRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 5,325,000 | $437,822 | +5% | 7.99% |
| 2. | Perceptive Advisors Joseph Edelman | 2,380,710 | $195,742 | -28% | 3.92% |
| 3. | OrbiMed Advisors Samuel Isaly | 1,630,500 | $134,060 | +15% | 2.17% |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,409,784 | $115,912 | 0.66% | |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 1,393,000 | $114,532 | +73% | 2.38% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $97.50 | 50,000 | Large Shareholder | 1,765,560 | 2020-01-10 | Filing | |
| $62.00 | 150,000 | Large Shareholder | 1,715,560 | 2019-01-17 | Filing | |
| $38.85 | 400,000 | Large Shareholder | 4,798,101 | 2018-06-11 | Filing | |
| $38.85 | 193,050 | Large Shareholder | 1,565,560 | 2018-06-07 | Filing | |
| $13.00 | 255,264 | Large Shareholder | 3,135,966 | 2017-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.54 | 624 | 86,804 | 2022-05-23 | Filing | ||
| $106.34 | 210 | 6,021 | 2022-02-11 | Filing | ||
| $105.80 | 8,700 | 6,231 | 2022-02-11 | Filing | ||
| $104.76 | 2,090 | 14,931 | 2022-02-11 | Filing | ||
| $116.07 | 1,475 | 2,546 | 2022-01-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 287,660 | $23,651,406 | 0.01% | |
| 2. | 50,315 | $4,136,899 | 0.03% | |
| 3. | 27,147 | $2,232,026 | 0% | |
| 4. | 4,482,810 | $368,577 | 0% | |
| 5. | 3,135,966 | $257,839 | 68.01% |
News See All
Top 10 Stocks Billionaire Mets Owner Steve Cohen Just Added to His Portfolio
In this article we present the list of top 10 stocks billionaire Mets owner Steve Cohen just added to his portfolio.
Is Mirati Therapeutics (MRTX) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Opportunity Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Did Hedge Funds Get Mirati Therapeutics, Inc. (MRTX) Right?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Top 10 Stock Picks of Samuel Isaly’s OrbiMed Advisors
In this article, we discuss the top 10 stock picks of Samuel Isaly's OrbiMed Advisors.
Hedge Funds Are Dumping Mirati Therapeutics, Inc. (MRTX)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
5 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Is Mirati Therapeutics (MRTX) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Was The Smart Money Right About Mirati Therapeutics, Inc. (MRTX)?
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database.
Top Investors’ Stock Portfolio: 5 Mid-Cap Stocks To Buy
In this article, we discuss the top 5 mid-cap stocks to buy.
Billionaire Hedge Funds
